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In Brief
An important milestone in forebrain
neuronal development is the switch in
composition of the NMDA receptor:
GluN2A becomes incorporated into
previously GluN2B-dominated NMDARs.
Using knockin mice, McKay et al. find
that, contrary to earlier proposedmodels,
the switch does not require GluN2A and
GluN2B to possess distinct C-terminal
domain sequences.
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https://doi.org/10.1016/j.celrep.2018.09.089SUMMARY
The GluN2 subtype (2A versus 2B) determines bio-
physical properties and signaling of forebrain
NMDA receptors (NMDARs). During development,
GluN2A becomes incorporated into previously
GluN2B-dominated NMDARs. This ‘‘switch’’ is pro-
posed to be driven by distinct features of GluN2
cytoplasmic C-terminal domains (CTDs), including a
unique CaMKII interaction site in GluN2B that drives
removal from the synapse. However, these models
remain untested in the context of endogenous
NMDARs. We show that, although mutating the
endogenous GluN2B CaMKII site has secondary
effects on GluN2B CTD phosphorylation, the devel-
opmental changes in NMDAR composition occur
normally andmeasures of plasticity and synaptogen-
esis are unaffected. Moreover, the switch proceeds
normally in mice that have the GluN2A CTD replaced
by that of GluN2B and commences without an
observable decline in GluN2B levels but is impaired
by GluN2A haploinsufficiency. Thus, GluN2A expres-
sion levels, and not GluN2 subtype-specific CTD-
driven events, are the overriding factor in the devel-
opmental switch in NMDAR composition.
INTRODUCTION
NMDARs (N-methyl-D-aspartate [NMDA] receptors) are gluta-
mate-gated cation channels with high Ca2+ permeability that
play key roles in CNS processes, such as synaptic transmission,Cell
This is an open access article undlearning and memory, development, neuroprotective signaling,
and redox balance, as well as in neurodegenerative and neuro-
logical disorders (Baxter and Hardingham, 2016; Bell and Hardi-
ngham, 2011a, 2011b; Paoletti et al., 2013). Most NMDARs
contain two obligate GluN1 subunits and two GluN2 subunits,
of which there are four types (2A–D), with GluN2A and GluN2B
being predominant in the forebrain. The importance of the iden-
tity of NMDAR subtypes (GluN2A versus GluN2B) in humans is
illustrated by the phenotypes of patients with mutations in the
genes that encode them (GRIN2A and GRIN2B), which include
intellectual disability, autism, epilepsy, and schizophrenia (Bur-
nashev and Szepetowski, 2015; Hardingham and Do, 2016).
The GluN2 subtype dictates NMDAR biophysical properties,
including agonist affinity, open probability, and deactivation ki-
netics (Paoletti et al., 2013; Wyllie et al., 2013), thus influencing
the downstream consequences of NMDAR activation, such as
the properties of plasticity and metaplasticity in the cortex
(Cooke and Bear, 2013; Philpot et al., 2003). In addition, NMDAR
composition can influence downstream NMDAR signaling to
synaptic plasticity, cognition, and excitotoxicity by virtue of their
highly divergent cytoplasmic C-terminal domains (CTDs) (Martel
et al., 2012; Ryan et al., 2008, 2013). During forebrain develop-
ment, there is a shift in NMDAR subunit composition, from
near-exclusively GluN2B-containing NMDARs to NMDARs con-
taining a significant GluN2A contribution, e.g., GluN12-GluN2A2
diheteromeric receptors and GluN12-GluN2A-GluN2B trihetero-
meric receptors (Wyllie et al., 2013). This has been referred to as
the ‘‘switch’’ in composition, which is partly experience depen-
dent and takes place over postnatal weeks 2–5 in mice.
A prominent model for the mechanism by which GluN2A
becomes incorporated into NMDARs at the expense of GluN2B
involves a series of phosphorylation events centered on the CTD
of GluN2B (CTD2B) and initiated by CaMKIIa binding to itsReports 25, 841–851, October 23, 2018 ª 2018 The Author(s). 841
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
GluN2B-specific interaction site (Lussier et al., 2015; Sanz-
Clemente et al., 2010, 2013). CaMKIIa has been proposed to re-
cruit casein kinase 2 (CK2) to phosphorylate CTD2B at serine-
1480, leading to the dissociation of the MAGUK-Fyn complex
and reduction in CTD2B tyrosine-1472 phosphorylation (a target
of Fyn), destabilizing GluN2B’s presence at the synapse and ul-
timately triggering AP-2-mediated endocytosis (Lavezzari et al.,
2003; Sanz-Clemente et al., 2010, 2013). Because this model is
based on observations of the properties of ectopically expressed
mutant subunits, we wanted to gain insight into the role of
GluN2B CTD-specific sequences in the developmental switch
of endogenous NMDAR subunits and have approached this by
studying receptors that have beenmodified at the genomic level.
RESULTS
Mutation of the GluN2B CaMKII Site Influences
Phosphorylation of Its CTD
To study the role of the endogenous CTD2B CaMKII binding site,
we generated a knockin mouse, containing three mutations in
the GluN2B CTD2B sub-region (L1298A/R1300N/S1303D), here-
after referred to as GluN2BDCaMKII (Figures 1A and S1A). The
combined L1298A/R1300N mutation is sufficient to abrogate
CaMKII binding to GluN2B, as has the additional S1303D muta-
tion in vitro (Strack et al., 2000), which mimics the CaMKII-
dependent phosphorylation event that inhibits its own binding
(Strack et al., 2000). The homozygote GluN2BDCaMKII/DCaMKII
mice were healthy and fertile, but to provide wild-type controls
for the GluN2BDCaMKII/DCaMKII neurons within the same litter,
our approach was to perform heterozygous intercrosses. Co-
immunoprecipitation of NMDARs (using an N-terminal antibody
to GluN2B) with CaMKIIa was reduced by around 40% (Figures
1H and 1I), a reduction similar to that observed with a previously
described GluN2B L1298A/R1300N knockin (Halt et al., 2012).
The remaining co-immunoprecipitation may be due to CaMKIIa
association with GluN1 (Leonard et al., 2002).
We first studied CTD2B phosphorylation in
GluN2BDCaMKII/DCaMKII neurons, observing a reduction in
CTD2B Ser-1480 phosphorylation and an increase in Tyr-
1472 phosphorylation in cortical neurons at both day in vitro
9 (DIV9) and DIV16 (Figures 1B and 1C), consistent with a
role for CaMKII in recruiting casein kinase 2 to CTD2B, causing
a reduction in Fyn recruitment (Lavezzari et al., 2003;
Sanz-Clemente et al., 2010, 2013). As expected,
GluN2BDCaMKII/DCaMKII was also immunonegative for the phos-
pho-Ser-1303 site (Figure 1C).
It has been shown that overexpressing constitutively active
Fyn enhances synaptic localization of wild-type GluN2B by
around 15% in a Tyr-1472-dependent manner (Prybylowski
et al., 2005), so we studied synaptic versus extrasynaptic
localization. At an age (DIV9) when NMDAR currents are
almost entirely mediated by GluN2B-containing NMDARs,
GluN2BDCaMKII/DCaMKII neurons were found to have a similar
proportion of extrasynaptic NMDAR currents as neurons from
GluN2BWT/WT littermates (Figure 1E).We alsomeasured synaptic
and extrasynaptic GluN2B levels in the neocortex (Figure S1B)
and the hippocampus (Figure S1C) of P28 GluN2BDCaMKII/DCaMKII
mice, using biochemical fractionation of synaptosome prepara-842 Cell Reports 25, 841–851, October 23, 2018tions (Martel et al., 2012), again revealing no genotype-depen-
dent differences. Thus, the relatively modest changes in CTD
phosphorylation in GluN2BDCaMKII/DCaMKII neurons appeared to
be insufficient to significantly affect NMDAR localization. This
is consistent with observations that complete exchange of the
GluN2B CTD with that of GluN2A does not influence synaptic
versus extrasynaptic localization (Martel et al., 2012).
The GluN2B CaMKII Site Is Dispensable for the
Developmental Switch In Vitro and In Vivo
To investigate the role of the endogenous CTD2B CaMKII in the
developmental change in NMDAR subunit composition, we first
studied primary cortical neurons, which show increased GluN2A
incorporation during the 2nd week in vitro. NMDAR current
density in the cortical neurons increased between DIV8 and
DIV14–18 and was not different in GluN2BDCaMKII/DCaMKII neu-
rons versus GluN2BWT/WT neurons (Figure 1D). Moreover, we
observed the expected developmental increase in the GluN2A:
GluN2B ratio (protein) in both genotypes (Figures 1F and 1G).
To assess changes in subunit composition, a standard approach
is to assess the sensitivity of NMDAR currents to a GluN2B-
selective antagonist, such as ifenprodil. We observed a drop in
the ifenprodil sensitivity of NMDAR currents between DIV8 and
DIV14–18 in GluN2BWT/WT neurons as expected (Figure 1J) but
also a similar drop in currents from GluN2BDCaMKII/DCaMKII
neurons.
The degree of the drop in ifenprodil sensitivity is limited by the
fact that GluN12-GluN2B2 diheteromeric receptors are only
maximally blocked by around 80%, and GluN12-GluN2A-
GluN2B triheteromeric receptors, which contribute to NMDAR
currents in mature forebrain neurons, are still blocked by around
30% (Stroebel et al., 2014). We therefore took an additional
approach, exploiting the strong GluN2B-specific potentiation
of NMDAR currents by spermine at 30 mV (pH 6.5; Mony
et al., 2011), observed in GluN12-GluN2B2 NMDARs, but not
GluN12-GluN2A-GluN2B or GluN12-GluN2A2 NMDARs (Stroebel
et al., 2014). We validated the approach in neurons from a
GluN2A/ rat line we recently generated: cortical neurons
from GluN2A+/+, but not GluN2A/, littermates showed a devel-
opmental drop in spermine potentiation of NMDAR currents (Fig-
ure S1D). Applying this technique to GluN2BWT/WT versus
GluN2BDCaMKII/DCaMKII mouse cortical neurons, we observed a
developmental drop in spermine potentiation in GluN2BWT/WT
neurons, which was equally strong in GluN2BDCaMKII/DCaMKII neu-
rons (Figures 1K and 1L). Collectively, these data show that the
GluN2B CaMKII site is not required for normal developmental
changes in NMDAR subunit composition in primary cortical
neurons.
An advantage of employing a knockin mouse model is that the
role of the GluN2B CaMKII site can be studied in vivo. In protein
extracts from the neocortex and hippocampus of GluN2BWT/WT
and GluN2BDCaMKII/DCaMKII mice, we observed the expected in-
crease in GluN2A expression between postnatal day 14 (P14)
and P28 (Figures 1M, 1N, and S1E). We prepared postsynaptic
density (PSD) fractions and measured the GluN2A:GluN2B ratio,
finding that the expected developmental increase in the Glu-
N2A:GluN2B ratio in synaptic NMDARs in GluN2BWT/WT mice
was also observed in GluN2BDCaMKII/DCaMKII mice in the
(legend on next page)
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neocortex (Figures 1O and 1P) and hippocampus (Figure S1F).
Thus, targeted mutation of the endogenous GluN2B CaMKII
site has no apparent effect on the developmental shift in synaptic
NMDAR subunit composition.
The GluN2B CaMKII Site Is Dispensable for
Synaptogenesis and Theta Burst LTP
The GluN2B CaMKII site has been proposed to be important for
synaptic NMDAR signaling to the ERK1/2 pathway: overex-
pressing a CaMKIIamutant defective in GluN2B binding reduces
NMDAR-dependent ERK1/2 activation (El Gaamouch et al.,
2012). We analyzed basal ERK1/2 activity in DIV9 cortical cul-
tures, which is maintained by synaptic NMDAR activity (sensitive
to TTX and MK-801) and is partly CaM-kinase-dependent
(sensitive to KN-62; Chandler et al., 2001; El Gaamouch et al.,
2012). Studying wild-type, GluN2BDCaMKII/DCaMKII, and
GluN2B2A(CTR)/2A(CTR) neurons, we found a significant effects of
both TTX, MK-801, and KN-62 on basal levels, confirming previ-
ous observations, but no genotype-dependent differences in
ERK1/2 activity (Figures 2A and 2B). To test whether any
GluN2B-specific CTD sequences are needed for signaling to
ERK1/2, we performed the same experiment on neurons
cultured from GluN2B2A(CTR)/2A(CTR) pups, a knockin line in which
GluN2B CTD has been replaced by that of GluN2A (Martel et al.,
2012; Ryan et al., 2013). Compared to neurons cultured from
GluN2BWT/WT littermates, we again observed no genotype-
dependent differences in activity-dependent ERK1/2 activity
(Figures 2A and 2C), suggesting that this does not have a
requirement for GluN2B-specific CTD sequences.
An additional putative role of the GluN2B CaMKII interaction
site is in excitatory synaptogenesis, based on the effects of
overexpression of a GluN2B mutant impaired in CaMKII binding
(RS/QD: R1300Q;S1303D; Gambrill and Barria, 2011). Analysis
of miniature excitatory postsynaptic current (mEPSC) size
and frequency revealed that they were unaltered in
GluN2BDCaMKII/DCaMKII mice (Figures 2D–2F). Consistent withFigure 1. The GluN2B CaMKII Site Is Dispensable for the Development
(A) Schematic of the GluN2BDCaMKII amino acid changes.
(B and C) Altered GluN2B phosphorylation in GluN2BDCaMKII/DCaMKII neurons. Co
indicated antibodies, normalized to total GluN2B. (B) shows quantitation (mean
GluN2B+/+ (n = 4).
(D) NMDAR current density at the indicated ages for GluN2BWT/WT and GluN2BDCa
way ANOVA plus Sidak’s post hoc test (GluN2BWT/WT: n = 14 [DIV7 or DIV8], n = 1
(E) Extrasynaptic NMDAR currents were measured in GluN2BWT/WT and GluN2B
(F and G) GluN2A and GluN2B expression analyzed by western blot at DIV8 and
titation and (G) shows an example. *p < 0.05 versus DIV8 of the same genotype;
(H and I) Neocortices of GluN2BWT/WT and GluN2BDCaMKII/DCaMKII mice were sub
followed by analysis of GluN2B and CaMKIIa content. (H) shows an example and
(J) Percentage blockade of NMDAR currents by ifenprodil (3 mM) at the indicated
DIV7 or DIV8 of the same genotype; two-way ANOVA plus Sidak’s post hoc test (
n = 15 [DIV7 or DIV8], n = 17 [DIV14–18]).
(K and L) Percentage potentiation of NMDAR currents by 100 mM spermine was
neurons. *p < 0.05 versus DIV7 or DIV8 of the same genotype; two-way ANOVA plu
GluN2BDCaMKII/DCaMKII: n = 18 [DIV7 or DIV8], n = 14 [DIV14–18]). (K) shows quan
(M and N) Neocortical extracts from P14 and P28 mice were analyzed for GluN2
example. *p < 0.05 versus P14 of the same genotype; two-way ANOVA plus Sid
(O and P) Post-synaptic density (PSD) extracts from P14 and P28 mice of the indic
to b-actin, and the ratio calculated. (O) shows quantitation and (P) shows an exam
post hoc test (n = 8).
844 Cell Reports 25, 841–851, October 23, 2018this, field excitatory postsynaptic potential (fEPSP) recordings
by multi-electrode array revealed similar input-output curves in
both genotypes (Figure S2A). Also, a comparison of fEPSP
slopes and presynaptic fiber volley amplitudes in fEPSP record-
ings by conventional glass electrodes also revealed no differ-
ence between genotypes (Figures S2B and S2C). Given that
CaMKIIa activity is implicated in synaptogenesis, we looked at
the levels of phospho-Thr286 CaMKIIa in hippocampal postsyn-
aptic densities and found them to be similar in mice of both
genotypes also (Figure S2D). We also probed the NMDAR
properties and subunit composition in the hippocampal CA1
synapses. NMDAR:AMPAR ratios were similar in neurons of
GluN2BWT/WT and GluN2BDCaMKII/DCaMKII mice (Figure 2G), as
was the decay kinetics of EPSCs recorded at +40 mV (Figures
2H and 2I), which is dictated by the dissociation rate of glutamate
from NMDARs and is slower for GluN2B than GluN2A (Paoletti
et al., 2013).
An additional putative role of the GluN2B CaMKII interaction
site is in hippocampal theta burst (TBS) long-term potentiation
(Barria and Malinow, 2005), known to involve both CaMKII and
ERK1/2 activation (Winder et al., 1999; Barria and Malinow,
2005; Ito et al., 1991). We found that TBS-long term potentiation
(LTP) was not significantly different in GluN2BDCaMKII/DCaMKII
versus GluN2BWT/WT slices (Figures 2J and 2K; n = 8 animals
per genotype), suggesting that the GluN2B CaMKII site is not
critical for this form of NMDAR-dependent synaptic plasticity.
Distinct GluN2 CTDs Are Not Required for the NMDAR
Developmental Switch
We next addressed a more general question as to whether the
NMDAR subunit switch has any requirement for GluN2-specific
CTD sequences. To investigate this, we utilized another knockin
mouse, GluN2A2B(CTR) (Figure 3A), in whichwe replaced the exon
encoding the CTD of GluN2A with that of GluN2B (Ryan et al.,
2013), meaning that both GluN2A and GluN2B have the same
CTD. NMDAR current density in GluN2A2B(CTR)/2B(CTR) neuronsal Switch In Vitro
rtical neuronal extracts were prepared and analyzed by western blot with the
± SEM here and throughout), and (C) shows an example. *p < 0.05 versus
MKII/DCaMKII neurons. *p < 0.05 versus DIV7 or DIV8 of the same genotype; two-
8 [DIV14–18]; GluN2BDCaMKII/DCaMKII: n = 15 [DIV7 or DIV8], n = 17 [DIV14–18]).
DCaMKII/DCaMKII neurons (n = 8 per genotype).
DIV16 for GluN2BWT/WT and GluN2BDCaMKII/DCaMKII neurons. (F) shows quan-
two-way ANOVA plus Sidak’s post hoc test (n = 8).
jected to immunoprecipitation with an antibody to the N terminus of GluN2B,
(I) shows quantitation. *p < 0.05; n = 8 per genotype.
stages for GluN2BWT/WT and GluN2BDCaMKII/DCaMKII neurons. *p < 0.05 versus
GluN2BWT/WT: n = 14 [DIV7 or DIV8], n = 18 [DIV14–18]; GluN2BDCaMKII/DCaMKII:
measured at the indicated stages for GluN2BWT/WT and GluN2BDCaMKII/DCaMKII
s Sidak’s post hoc test (GluN2BWT/WT: n = 13 [DIV7 or DIV8], n = 18 [DIV14–18];
titation and (L) shows example traces; scale bar: 200 pA/2 s.
A expression, normalized to b-actin. (M) shows quantitation and (N) shows an
ak’s post hoc test (n = 8).
ated genotype were analyzed for GluN2A and GluN2B expression, normalized
ple. *p < 0.05 versus P14 of the same genotype; two-way ANOVA plus Sidak’s
Figure 2. The GluN2B CaMKII Binding Site
Is Dispensable for Theta Burst LTP
(A–C) Activity-dependent signaling to ERK1/2
does not require GluN2B CTD-specific se-
quences. DIV9 cortical neurons of the indicated
genotypes were treated with TTX (500 nM), KN-62
(10 mM), or MK-801 (10 mM) for 1 hr, after which
protein extracts were made and subjected to
western blot analysis for phospho-ERK1/2 levels,
normalized to total ERK1/2. (A) shows quantitation
and (B) and (C) show example blots.*p < 0.05 two-
way ANOVA plus Dunnett’s post hoc test. No
genotype-dependent effects were observed
(p = 0.39) or genotype-drug interactions (p = 0.16;
n = 8 GluN2BWT/WT; n = 4 GluN2BDCaMKII/DCaMKII;
n = 4 GluN2B2A(CTR)/2A(CTR)).
(D–F) Cumulative probability plots show amplitude
(D) and frequency (E) of miniature EPSCs in
GluN2BWT/WT and GluN2BDCaMKII/DCaMKII slices.
Results are from 11 cells from 3 GluN2BWT/WT
mice and 13 cells from 3 GluN2BDCaMKII/DCaMKII
mice; p = 0.75 (amplitude); p = 0.94 (frequency);
unpaired t test. (F) shows example traces. Scale
bar: 10 pA/100 ms.
(G) NMDAR:AMPAR EPSC ratios at 80
and +40 mV was measured in GluN2BWT/WT
(n = 25; 4 mice) and GluN2BDCaMKII/DCaMKII (n = 30;
4 mice) neurons (unpaired t test; p = 0.95).
(H) Weighted time constant (tw) for the decay of
EPSCs recorded in (A) at +40 mV was determined
using double exponential fits (unpaired t test;
p = 0.63).
(I) Example traces. Scale bar: 100 pA/20 ms.
(J and K) Theta-burst stimulation elicited pathway-
specific LTP of synaptic transmission in hippo-
campal CA1 area. Normalized magnitude of this
potentiation 60–65 min after LTP induction did not
differ significantly in GluN2BWT/WT mice (29 slices;
n = 9) compared to GluN2BDCaMKII/DCaMKII (35 sli-
ces; n = 11); p = 0.162 (two-way nested ANOVA).
(J) shows quantitation of data and (K) shows
example traces before and after LTP induction.
(K) Traces show example fEPSP traces immedi-
ately before and 1 hr after theta-burst stimulation.
Scale bar: 0.5 mV/2 ms.was found to be no different toGluN2AWT/WT neurons (Figure 3B).
Importantly, the developmental drop in NMDAR current potenti-
ation by spermine was identical in GluN2A2B(CTR)/2B(CTR) and
GluN2AWT/WT neurons (Figures 3C and 3D), as was ifenprodil
sensitivity of NMDAR currents (Figure S3A). We also observed
no difference in the synaptic versus extrasynaptic localization
of NMDARs: in DIV14–18 neurons, neither the proportion of
extrasynaptic NMDAR currents nor their sensitivity to ifenprodil
was different in GluN2A2B(CTR)/2B(CTR) neurons compared to
GluN2AWT/WT neurons (Figures S3B and S3C). Moreover, the
developmental increase in GluN2A expression in the neocortex
and hippocampus of GluN2A2B(CTR)/2B(CTR) and GluN2BWT/WT
mice was indistinguishable (Figures 3E, 3F, and S3D).Cell RFurthermore, the developmental increase
in the synaptic GluN2A:GluN2B ratio in
cortical (Figures 3G and 3H) and hippo-campal (Figure S3E) tissue was also similar. Thus, even when
GluN2A andGluN2B possess identical CTDs, the developmental
shift in NMDAR subunit composition, and their targeting to syn-
aptic or extrasynaptic locations, proceeds normally in vitro and
in vivo.
Increased Expression of GluN2A Is a Key Determinant of
the Shift in Subunit Composition
It has been proposed that epigenomic repression of GluN2B is
a contributing factor to the developmental increase in
GluN2A:GluN2B ratio in the hippocampus (Rodenas-Ruano
et al., 2012). However, the extent to which GluN2B repression
drives the subunit switch in the cortex, compared to GluN2Aeports 25, 841–851, October 23, 2018 845
Figure 3. Distinct GluN2 CTDs Are Not Required for the 2B-to-2A Switch
(A) Schematic illustrating the C-terminal domain exchange in the GluN2A2B(CTR)/2B(CTR) mouse.
(B) NMDAR current density in GluN2AWT/WT (n = 30) and GluN2A2B(CTR)/2B(CTR) (n = 24) neurons, recorded DIV14–18.
(C and D) Percentage potentiation of NMDAR currents by 100 mM spermine was measured in GluN2AWT/WT and GluN2A2B(CTR)/2B(CTR) neurons. *p < 0.05 versus
DIV7 or DIV8 of the same genotype; two-way ANOVA plus Sidak’s post hoc test (GluN2AWT/WT: n = 19 [DIV7 or DIV8], n = 18 [DIV14–18]; GluN2A2B(CTR)/2B(CTR): n =
16 [DIV7 or DIV8], n = 17 [DIV14–18]). (C) shows quantitation of data and (D) shows example traces; scale bar: 200 pA/2 s.
(E and F) Neocortical extracts fromP14 and P28mice of the indicated genotype were analyzed for GluN2A expression, normalized to b-actin. *p < 0.05 versus P14
of the same genotype; two-way ANOVA plus Sidak’s post hoc test (n = 8). (E) shows quantitation and (F) shows example blots.
(G and H) PSD extracts from P14 and P28mice of the indicated genotype were analyzed for GluN2A and GluN2B expression, normalized to b-actin, and the ratio
calculated and scaled such that the ratio at P14 for WT = 1. *p < 0.05 versus P14 of the same genotype; two-way ANOVA plus Sidak’s post hoc test (n = 8). (G)
shows quantitation and (H) shows an example blot.upregulation, is unclear. We recently showed that GluN2B protein
levels are around 10-fold higher than GluN2A in the adult cortex
(Frank et al., 2016), suggesting that the GluN2A:GluN2B ratio is
more sensitive to an increase in GluN2A than an equivalent fall
in GluN2B. We measured total GluN2B expression in the
neocortex at P14 and P28 from wild-type, GluN2A2B(CTR)/2B(CTR),
and GluN2BDCaMKII/DCaMKII mice and found no evidence for
decreasing GluN2B expression (Figures 4A–4D), consistent with
other studies on the cortex (Liu et al., 2004; Sheng et al., 1994).
Thus, the developmental shift in NMDAR subunit composition in
the developing cortex can commence without the substantial
repression of GluN2B expression, as well as without GluN2B
CTD-dependent removal of GluN2B-containing NMDARs from
the synapse (Figure 3). This suggests that the overriding factor
is simply the increasing level of GluN2A expression. Indeed, by
analyzing spermine potentiation of currents in DIV14 and DIV15
cortical neurons from GluN2A+/+, GluN2A+/, and GluN2A/
rats, we observed a negative correlation with gene copy number846 Cell Reports 25, 841–851, October 23, 2018(Figures 4H and 4I). This points to impairment in the replacement
of GluN12-GluN2B2 NMDARs with GluN12-GluN2A-GluN2B and
GluN12-GluN2A2 NMDARs, due to haploinsufficiency of the
Grin2a gene, suggesting that GluN2A levels are the limiting factor
in dictating the switch. As expected, the reverse was also found:
GluN2A overexpression in young rat or mouse neurons has a very
modest effect on NMDAR currents (Martel et al., 2012) but
resulted in a very strong reduction of NMDAR current potentiation
by spermine (Figures 4E–4G). Thus, a major determinant of the
developmental shift in NMDAR subunit composition is the
increasing expression of GluN2A.
DISCUSSION
Probing Channel Domain Function Using Knockin
Mouse Models
Our experiments point to the value of probing putative signaling
domains within ion channels and receptors by targeted genetic
Figure 4. GluN2A Expression Is Sufficient to Displace GluN2B from NMDARs
(A–D) Total GluN2B expression was measured in extracts from the neocortex at the indicated stages for the indicated genotypes (n = 8 per genotype). (A) and (B)
show quantitation and example blots, respectively, for GluN2AWT/WT versus GluN2A2B(CTR)/2B(CTR). (C) and (D) show quantitation and example blots, respectively,
for GluN2AWT/WT vs. GluN2BDCaMKII/DCaMKII.
(E–G) Ectopic GluN2A expression is sufficient to displace GluN2B from NMDARs. Young mouse (E and F) and rat (G) neurons at DIV7 were transfected with a
control (b-globin) or GluN2A-encoding vector and spermine (100 mM) potentiation of NMDAR currents measured 72 hr later. *p < 0.05 (F: n = 10 of both condition;
G: n = 8 control; n = 10 GluN2A).
(H) Percentage potentiation of NMDAR currents by spermine (200 mM) in DIV15 or DIV16 rat cortical neurons wasmeasured at the indicated stages for GluN2A+/+,
GluN2A+/, and GluN2A/ genotypes. Person r correlation coefficient: 0.9954; p = 0.031 (one-tailed test); n = 12 cells per genotype.
(I) Western blot illustrating GluN2A expression in GluN2A+/+, GluN2A+/–, and GluN2A–/– neurons.
(I) A western blot confirming the absence of GluN2A expression in GluN2A/ and an intermediate expression level in GluN2A+/ neurons.approaches, as opposed to reliance on ectopic expression of
mutant receptors. For example, compared to overexpression
of wild-type GluN2B, overexpression of the GluN2B CaMKII
site R1300Q/S1303D mutant in cultured hippocampal neurons
impairs functional synaptogenesis, assayed by mEPSC fre-
quency and spine number (Gambrill and Barria, 2011). In
contrast, we found normal mEPSC size and frequency in hippo-
campal slices of GluN2BDCaMKII/DCaMKII mice, consistent with a
report of normal synaptogenesis in an independently created
CaMKII site mutant knockin mouse (Halt et al., 2012). Further-
more, a recent study proposed that GluN2B’s CamKIIa interac-
tion site is important for correct basal AMPA-receptor-mediated
synaptic transmission (Incontro et al., 2018), based on results of
acute virus-delivered CRISPR deletion of the endogenous
GluN2B gene in slice culture and ectopic expression of mutant
versus wild-type (WT) subunits. In contrast, we see normal basalhippocampal synaptic transmission in GluN2BDCaMKII/DCaMKII
mice (Figures 2 and S2), again consistent with the observations
made previously in a different knockin model (Halt et al., 2012).
Furthermore, overexpression of another GluN2B CaMKII site
mutant (S1303E) led to a higher increase in GluN2B surface
expression than WT GluN2B overexpression (Sanz-Clemente
et al., 2013), whereas we found normal NMDAR currents in
GluN2BDCaMKII/DCaMKII neurons. Moreover, expression of the
CaMKII site mutant of GluN2B increased the GluN2B:GluN2A
ratio at functional NMDARs in slice cultures, compared to the
wild-type GluN2B, as measured by studying the EPSC decay
constant (Sanz-Clemente et al., 2013). In contrast, our record-
ings in acute hippocampal slices revealed unaltered EPSC
decay constants in GluN2BDCaMKII/DCaMKII mice, indicative of a
normal synaptic GluN2B:GluN2A ratio, confirmed by biochem-
ical fractionation. What could explain the discrepancy betweenCell Reports 25, 841–851, October 23, 2018 847
observations based on knockin mouse lines versus overexpres-
sion of mutant subunits? One difference is that the latter may
alter the relative stoichiometry of GluN2B and CaMKIIa, which
could influence CaMKIIa interactions in the PSD. In the rat
brain PSD, CaMKIIa is 50 times more abundant than GluN2B
and 35- to 100-fold more abundant than GluN1 (Lowenthal
et al., 2015; Cheng et al., 2006). As such, mutating the
endogenous GluN2B CaMKIIa site in a knockin is unlikely to
influence the total synaptic or PSD-localized CaMKIIa.
However, overexpression of GluN2B and mutant variants
could alter the stoichiometric balance and cause the interaction
of GluN2B with a greater proportion of CaMKIIa at the synapse
and elsewhere. Of note, however, we did find that germline
mutation of the GluN2B CaMKII site rendered neurons less
vulnerable to excitotoxic insults (unpublished observation),
consistent with previous findings based on overexpression of
mutant subunits lacking this site (Vieira et al., 2016). Thus,
results from ectopic subunit expression are not always in
disagreement with conclusions derived from equivalent knockin
models.
Although theGluN2BCaMKII site may have a limited role in the
general developmental subunit switch in the cortex, it remains a
possibility that it plays a role in more specialized situations, such
as the experience or activity-dependent element of the 2B-to-2A
switch that occurs in the developing visual cortex (Quinlan et al.,
1999). It will be of interest to determine whether this process
has a requirement for GluN2 CTD subtype-specific events,
particularly because overexpression studies have implicated
the GluN2B CaMKII site in activity-dependent subunit switching
(Sanz-Clemente et al., 2013).
Additionally, although our study argues against a role for the
GluN2B CaMKII site-dependent recruitment of CK2 in the
NMDAR subunit switch, it remains possible that CK2 could still
play a role in phosphorylating GluN2B Ser-1480, disrupting its
interactions with MAGUKs, leading to reduced surface expres-
sion (Chung et al., 2004) independent of the GluN2B CaMKII
site. We considered investigating the influence of the CK2
inhibitor TBB, used previously to implicate CK2 in the switch.
However, TBB is known to inhibit kinases DYRK1A, DYRK2,
DYRK3, PIM2, PIM3, and HIPK2 just as effectively as it inhibits
CK2 (Pagano et al., 2008). Indeed, the TBB target DYRK1A has
been shown to phosphorylate and positively influence the sur-
face expression of GluN2A (Grau et al., 2014; Altafaj et al.,
2008). Thus, DYRK1A inhibition by TBB could conceivably
reduce GluN2A levels via this mechanism. Another potential
issue is TBB cytotoxicity (Qaiser et al., 2014), so deletion of
CK2 may be a better approach to directly probe its role in
NMDAR subunit switching.
Interdependence of GluN2B Phosphorylation Sites
Our observations align with predictions based on previous
studies (Sanz-Clemente et al., 2013) that mutation of the GluN2B
CaMKII site would reduce Ser-1480 phosphorylation (a CK2 site;
Sanz-Clemente et al., 2010) and increase Tyr-1472 phosphoryla-
tion (a Fyn site; Nakazawa et al., 2001). However, although
increased Fyn-driven Tyr-1472 phosphorylation prevents
AP-2-mediated GluN2B endocytosis (Prybylowski et al., 2005;
Roche et al., 2001; Zhang et al., 2008), we did not observe848 Cell Reports 25, 841–851, October 23, 2018increased synaptic GluN2B in GluN2BDCaMKII/DCaMKII neurons.
One possible explanation is that the changes in phosphorylation
we observe (around 30%) were too small to have a significant
effect on synaptic GluN2B levels. Indeed, constitutive activation
of Fyn increased synaptic GluN2B-mediated NMDAR currents
by only around 15%, and a similar difference was observed
under basal conditions between GluN2B and non-phosphorylat-
able GluN2B-Y1472A overexpressing neurons (Prybylowski
et al., 2005). In a similar vein, the reduction in endocytosis
observed in ectopically expressed GluN2B-Y1472A compared
to ectopically expressed WT GluN2B is around 25% (Sanz-
Clemente et al., 2010). Thus, the changes observed even
when driving the system maximally by expressing mutant
subunits and constitutively active kinases are quite modest,
meaning that the relatively small changes in Y-1472 phosphory-
lation may not have a detectable effect on synaptic GluN2B
expression.
The GluN2B CaMKII Site in Synaptic Plasticity
Our findings regarding normal excitatory synaptogenesis and
synaptic transmission in the GluN2BDCaMKII/DCaMKII mouse are
consistent with observations made in an independently created
knockin mouse with a targeted mutation of the GluN2B CaMKII
site (Halt et al., 2012). One observation where our data do not
align is their reporting of a deficit (ca. 30%) in theta-burst LTP,
which we did not observe. One difference in our knockin lines
is our additional mutation (the phospho-mimetic S1303D),
chosen because, although R1300Q and S1303D both reduce
CaMKII-GluN2B interaction, the double mutant R1300Q/
S1303D reduces binding even further (Strack et al., 2000). The in-
clusion of the S1303D in GluN2B ‘‘CaMKII site’’ mutants has
been employed elsewhere (Barria and Malinow, 2005; Gambrill
and Barria, 2011; Vieira et al., 2016) but will alter the charge at
this site. However, whatever the approach used to disrupt
CaMKII binding, alteration of the charge at Ser-1303 is likely to
be unavoidable, because CaMKII is the major kinase at this
site and forebrain neurons have substantial basal S1303 phos-
phorylation (McQueen et al., 2017), which will likely decrease if
CaMKII association is disrupted. It is therefore likely that
mutating L1298 and R1300 alone may lower S1303 phosphory-
lation (Halt et al., 2012), reducing the negative charge at this site,
and our mutation of S1303D will increase the charge. Thus,
although there is no evidence that the charge at S1303 has
additional effects, this difference between the two knockin
models could explain the discrepancy in the LTP experiments
and requires further investigation.
Concluding Remarks
Our observations argue against a central role for CTD subtype-
specific events in the normal developmental subunit shift in
cortical NMDAR subunit composition and that an increase in
GluN2A expression is likely the major driver of GluN2A:GluN2B
ratio increases. Thus, although GluN2 subtype-specific CTD
sequences do influence excitotoxicity, plasticity, protein
complex formation, and behavioral repertoire (Frank et al.,
2016; Martel et al., 2012; Ryan et al., 2013), their role in direct-
ing neuronal development and maturation may be less
pronounced.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Animals
All animal experiments conformed to national and institutional guidelines including the Animals [Scientific Procedures Act] 1986 (UK),
and the Council Directive 2010/63EU of the European Parliament, and had full Home Office ethical approval. All animals were main-
tained in pathogen-free and light- (12hr light/ 12hr dark) and temperature-controlled conditions. Food and water were available ad
libitum. Animals were group-housed in conventional cages and were provided with environmental enrichment. Animals had not been
subject to previous procedures. P14 and P28 homozygous and wild-type mice of both sexes were used and were generated as a
result of heterozygous intercrosses to generate littermate controls. GluN2A2B(CTR)/2B(CTR) and GluN2BDCaMKII mice were maintained
on a C57BL/6J background. GluN2A/ rats were maintained on a Long Evans Hooded background, and E20.5 rats of all genotypes
were generated as a result of heterozygous intercrosses.
Primary cultures
Cortical mouse and rat neurons were cultured as described (Puddifoot et al., 2012) at a density of 9-133 104 neurons per cm2 from
E17.5 mice or E20.5 rats (mixed sexes) with Neurobasal growth medium supplemented with B27 (Invitrogen, Paisley, UK). Thee1 Cell Reports 25, 841–851.e1–e4, October 23, 2018
cultures were maintained at 37C with 5% CO2. Experiments were performed at DIV 8-18 as indicated. By DIV 8 the neurons are
capable of supporting synchronous synaptic activity, but NMDA receptors are primarily GluN2B-containing, whereas at DIV 18 there
is a substantial GluN2A component (Baxter et al., 2015; McKay et al., 2012).
Generation of the GluN2BDCaMKII and mouse
GluN2A2B(CTR)/2B(CTR) neurons (Ryan et al., 2013) were produced fromGluN2A2B(CTR)/2B(CTR) embryos resulting fromGluN2AWT/2B(CTR)
x GluN2AWT/2B(CTR) mating, which also yielded GluN2AWT/WT littermate controls. Specific details regarding the generation of
GluN2A2B(CTR) line can be found elsewhere (Ryan et al., 2013). The GluN2AWT allele was genotyped using primers (50-
CTTCTTTTCTTCAATGTGCACTCC 30) and (50-CTACATCATCAGAAGCCCACC 30) while the GluN2A2B(CTR) allele was
genotyped using primers (50-GGGGAAGTTACATGGTGGATTG-30) and (50-GGGATGATCAGTGCTTGCTTC-30).
Generation of the GluN2BDCaMKII mouse
An artificial polylinker containing Xho1 and HindIII restriction sites was inserted into the NotI and SalI sites of pSP72 (Promega), re-
sulting in pSP72-L. A Diphtheria Toxin A (DT-A) fragment driven by an MC1 promoter with a mouse SV40 polyadenylation signal was
digested with HindIII and XhoI, and inserted into the HindIII and SalI sites of pSP72-L, creating pSP72-L-DT-ApA (Yanagawa et al.,
1999). A previously generated GluN2B targeting vector was acquired and co-opted for construction of the GluN2B-CaMKII vector
(Delint-Ramirez et al., 2010). The GluN2B-CaMKII targeting vector included a neomycin phosphotransferase gene (Neo) driven by
a compound phosphoglycerate kinase (PGK) and EM7 promoter for kanamycin resistance in bacteria, andG418 resistance in murine
cells, respectively. Substitutions were introduced into the GluN2B 30 terminal exon by mutagenic PCR using primers, resulting in the
GluN2B-CaMKII vector. The GluN2B-CaMKII vector was then inserted into the NotI and XhoI sites of pSP72-L-DT-ApA, generating
the final GluN2B S1303D targeting vector. The targeting vector was linearized with NotI and electroporated into E14Tg2A (129/
OlaHsd) mouse embryonic stem (ES) cells (Hooper et al., 1987). ES cells colony selection was carried out using G418. Genomic
DNA was extracted from individually picked ES cell colonies and used for screening for targeting vector integration by long-range
PCR using primers P1 (ACGAGATCAGCAGCCTCTGTTCCAC) and P2 (GAGGCGGGGCGACCAGGAAGGC). P1, hybridizes to the
Neo cassette, P2 hybridizes to a region of genomic DNA that is 30 of the targeting vector 30 homology arm. The GluN2B C-terminal
exon was cloned from targeted ES cell lines and sequenced to confirm the presence of the mutated sites (data not shown). ES cell
clones were injected into C57BL/6J mouse blastocysts, which were then implanted into a pseudopregnant mouse. Chimeras were
identified from the offspring based on coat color. Male chimeras were crossed onto C57BL/6J females in order to obtain an F1 gen-
eration. Genomic DNA was extracted from F1 progeny and used for confirmation of germline transmission by PCR using primers P1
and P2, and primers P3 (TCAGTGCTTGCTTCACGGCAGC) and P4 (CTCCTCTCCAGCCTCCCACACT). P3 hybridizes to the GluN2B
C-terminal domain exon, and P4 to the NR2B 30 UTR. F1 heterozygotes were crossed onto transgenic mice expressing Cre recom-
binase under a CMV promoter to excise the Neo selection cassette. Neo removal in the F2 generation was assessed by PCR using
primers P3 and P4, which gives a 567 bp product for wild-typemice and a 628 bp product for mutant alleles without the Neo cassette,
and P4 and P5 (TGGAAGGATTGGAGCTACGGG), which gives a700 bp product only if the Neo cassette is present. Mice were gen-
otyped using primers P3 and P4. The line was further backcrossed onto C57BL/6J for 6 generations prior to the commencement of
experiments. Animals were treated in accordance with UK Animal Scientific Procedures Act (1986). All the experiments were per-
formed using wild-type and homozygous littermates.
Generation of the GluN2A–/– rat
Single cell Long Evans Hooded rat embryos underwent pronuclear microinjection of mRNA encoding the enzyme Cas9 and small
guide RNAs (sgRNA) binding to 50 and 30 of exon 8 of Grin2A, before being implanted into pseudopregnant mothers. The resulting
live births were screened by PCR for genomic deletions due to repair by non-homologous end joining of double stranded breaks
targeted to either side of exon 8. A 1065bp deletion spanning exon 8 (which encodes key pore forming domains of GluN2A) was
identified, and confirmed by sequencing (data not shown). Genotyping was performed using primer pairs P5 (AGGGAAGAAGGGAA
CAGGAG) with P6 (TCTCTGGGATTCAGTGCAGA) and P7 (AAGGCAGAGAGAGAGACAAAG) with P8 (ATGGCAGTTCCCAGTA
GCAT). P5 and P7 bind to 50 of the deletion, P6 binds to 30 of the deletion, and P8 binds within the deletion. The sgRNA design
and generation of the founder animals were performed by Horizon Discovery Group plc (St Loius, MO, USA). Animals were treated
in accordance with UK Animal Scientific Procedures Act (1986). All the experiments were performed using wild-type, heterozygous,
and homozygous littermates matched animals.
METHOD DETAILS
Cell culture electrophysiological recording and analysis
Whole cell patch clamp recordings were performed as described (Edman et al., 2012; Hardingham et al., 2007). Briefly, coverslips
containing cortical neurons were transferred to a recording chamber perfused (at a flow rate of 3-5 ml/min) with an external recording
solution composed of (in mM): 150 NaCl, 2.8 KCl, 10 HEPES, 2 CaCl2, 10 glucose and 0.1 glycine, pH 7.3 (320-330 mOsm). Tetro-
doxin (300 nM) was included to block action-potential driven excitatory events. Patch-pipettes were made from thick-walled
borosilicate glass (Harvard Apparatus, Kent, UK) and filled with a K-gluconate-based internal solution containing (in mM): potassium
gluconate 141, NaCl 2.5, HEPES 10, EGTA 11; pH 7.3 with KOH). Electrode tips were fire-polished for a final resistance ranging
between 3-5 MU. All NMDA currents were evoked by 150 mM NMDA and 100 mM glycine, bath applied using a perfusion system.
Currents were recorded at room temperature (21 ± 2C) using an axopatch 200B amplifier (Molecular Devices, Union City, CA).Cell Reports 25, 841–851.e1–e4, October 23, 2018 e2
Neuronswere voltage-clamped at –60mV and recordings were rejected if the holding current was greater than –100 pA or if the series
resistance drifted by more than 20% of its initial value (< 20 MU). Whole-cell currents were analyzed using WinEDR v3.2 software
(John Dempster, University of Strathclyde, UK).
To measure extrasynaptic NMDAR currents, synaptically-located NMDARs were blocked by the use-dependent antagonist
MK-801, in an activity-dependent manner as previously described (Martel et al., 2012). First, whole-cell NMDAR currents were re-
corded in voltage-clamp (150 mM NMDA, in Mg2+-free and TTX containing recording solution). Neurons were then switched to
current-clamp mode in normal Mg2+-containing, TTX-free medium in the presence of MK-801 (10 mM) and bicuculline (50 mM). After
5 minutes of neuronal firing, the neurons were switched back to voltage clamp and the whole-cell NMDA currents were re-assessed
as above; the slow off-rate of MK-801 ensures synaptic NMDARs remained blocked and only extrasynaptic NMDAR currents are
recorded.
To determine the ifenprodil-sensitivity of neurons, whole cell NMDA currents were recorded followed by the inclusion of 3 mM ifen-
prodil in the recording solution for a blocking period of 90 s. The whole cell NMDA current was the re-assessed, with 3 mM ifenprodil
included, and the % block calculated.
For determining spermine potentiation, neurons were initially voltage-clamped at 60mV using the internal solution and ACSF
described above. The neurons were then voltage clamped at 30 mV and switched to a recording solution composed of (in mM):
70 NaCl, 60 choline chloride, 2.8 KCl, 20 HEPES, 10 glucose, 0.1 glycine, pH 6.5. 100 mM pentetic acid was also included otherwise
rapid desensitization of the spermine potentiation occurred. NMDA currents were evoked (as described above) then potentiated by
100 mMand 200 mMspermine consecutively. 200 mMsperminewas originally included as an internal control: both 100 mMand 200 mM
spermine are on the linear part of the dose-response and an approximate 2-fold increase in potentiation was expected jumping from
100 mM to 200 mM spermine.
Slice electrophysiological recordings and analysis
For extracellular and EPSC recordings illustrated in Figures 2D–2I, S2B, and S2C, mice were deeply anaesthetised with halothane
and then sacrificed by cervical dislocation using techniques approved by UCLA Institutional Animal Care and Use Committee.
Following the dissection of the hippocampi from the rest of the brain, 400 mm thick hippocampal slices were cut using amanual tissue
chopper and then maintained at 30C in an interface-slice type recording chamber perfused with oxygenated (95% O2/5% CO2)
artificial cerebrospinal fluid (ACSF) containing 124 mM NaCl, 4.4 mM KCl, 25 mM NaHCO3, 1 mM NaH2PO4, 2 mM CaCl2,
1.2 mMMgSO4, and 10 mM glucose. Whole-cell voltage-clamp techniques were used to record AMPA receptor- and NMDA recep-
tor-mediated excitatory postsynaptic currents (EPSCs). In these experiments, slices were bathed in a modified ACSF containing
4.0 mMCaCl2, 4.0 mMMgSO4, 2.4 mMKCl, and 100 mMpicrotoxin. The CA3 region was removed to prevent bursting in the absence
of inhibition and slices were maintained at 30C in a submerged slice recording chamber. Recording electrodes (3–6 MOhms) were
filled with a solution containing 102 mM cesium gluconate, 17.5 mM CsCl, 10 mM TEA-Cl, 5 mM QX314, 4.0 mM Mg-ATP, 0.3 mM
Tris-GTP, and 20mMHEPES (pH = 7.2). EPSCs evoked by Schaffer collateral fiber stimulation at 0.2 Hz were recorded at membrane
potentials of 80 mV or +40 mV, and the AMPA receptor- and NMDA receptor-mediated components of the synaptic currents were
estimated by measuring EPSC amplitude 5 and 50 ms after EPSC onset, respectively. In these experiments, the intensity of presyn-
aptic fiber stimulation was adjusted to elicit EPSCswith peak amplitudes of approximately 200 pA at80mV. Spontaneousminiature
EPSCs were recorded at 80 mV in the presence of 1.0 mM TTX. A combination of template and threshold (6 pA) based event
detection routines in pClamp 10 (Molecular Devices) was used for mEPSC analysis. Extracellular recordings (Figures S2B and
S2C) were done under interface conditions and began after allowing the slices to recover for at least 1 hour. In the experiments
illustrated in Figures 2J, 2K, and S2A, fEPSPs were recorded by using microelectrode arrays (MEA60, Multi Channel Systems, Reut-
lingen, FRG). Input/output relationships and theta-burst stimulation-induced LTP were examined using hippocampal slice prepara-
tions and experimental conditions described in detail previously (Kopanitsa et al., 2006). Theta-burst stimulation consisted of 10
bursts of 100 Hz stimulation (4 pulses) delivered with an inter-burst interval of 200 ms. The magnitude of LTP present 60–65 minutes
post theta-burst stimulation was used for statistical comparisons.
PSD fractionation, co-immunoprecipitation and western blotting
To isolate PSD-enriched proteins (containing synaptic NMDARs) and we used an approach previously described for studying syn-
aptic and extrasynaptic NMDARpopulations (Martel et al., 2012). Briefly, brains fromP14 and P28micewere dissected, their cortices
removed and immediately placed in ice-cold homogenization buffer (10 mM Sucrose, 10 mM HEPES, supplemented with Protease
and Phosphatase Inhibitor Cocktail tablets (Roche, Burgess Hill, UK), pH 7.4). Tissue samples were homogenized with a teflon/glass
homogenizer then centrifuged (1,000 g, 10 min, 4C). The supernatant was collected and centrifuged at 12,000 g (20 min, 4C), after
which the pellet was resuspended twice in 4mMHEPES (containing 1mM EDTA, pH 7.4) by repeating the last centrifugation step. To
obtain the non-PSD enriched fraction, pellets were then resuspended in 20 mM HEPES, 100 mM NaCl and 0.5% Triton X-100 (pH
7.2). Samples were incubated 15min at 4Cwhile rotating gently, followed by centrifugation (12,000 g, 20 min, 4C). The supernatant
was collected (Non-PSD enriched fraction) and the pellet solubilized (in 20 mMHEPES, 0.15 mMNaCl, 1% Triton X-100, 1% sodium
deoxycholate (DOC), 1%SDS, 1mMDTT, pH 7.5) for a further 1h at 4Cwith gentle agitation. Finally, the samples were centrifuged at
10,000 g for 15 min (4C) and the supernatants were collected as PSD-enriched fractions. Fractions were stored at20C until west-
ern blotting, and used less than two weeks after preparation.e3 Cell Reports 25, 841–851.e1–e4, October 23, 2018
For co-immunoprecipitation, P28 cortices were homogenized in IP buffer (50 mM Tris HCl pH 9, 50 mM NaF, 20 mM ZnCl2, 1 mM
Na3VO4, 1:100 protease inhibitor cocktail set III (Merck Chemicals, Nottingham, UK), 0.5 mg/ml PMSF, 1%DOC) and centrifuged for
40 min at 25000 g. The protein concentration in the supernatant was measured (by BCA assay) and adjusted to 3.5 mg/ml using IP
buffer. Antigen binding was carried-out by adding of 2 mg of antibody (anti-GluN2B (N terminus,), or control IgG) to 1.75 mg of protein
extract. The antibody-antigen mixture was incubated overnight with rotation at 4C. 50 ml Dynabeads were used per immunopre-
cipitation reaction incubation, and were aliquoted to each antigen-antibody mixture. Beads were incubated with the antibody for
20 min at room temperature on a rotator. The Dynabead-antibody-antigen complex was then washed four times in IP buffer, before
being eluted by suspending the beads in 40 mL of 1.5x 40 mL of 1.5x LDS sample buffer (NuPage, Life Technologies) and boiling for
10 min. The supernatant was then stored at 80C until SDS-PAGE and western blotting was carried out.
For western blotting, a procedure similar to that previously described was employed (Baxter et al., 2011). In order to minimize the
chance of post-translational modifications during the harvesting process, neurons were lysed immediately after stimulation in 1.5x
LDS sample buffer (NuPage, Life Technologies) and boiled at 100C for 10 min. Approximately 10 mg of protein was loaded onto a
precast gradient gel (4%–12%) and subjected to electrophoresis. Briefly, western blotting onto a PVDF membrane was then
performed using the Xcell Surelock system (Invitrogen) according to the manufacturer’s instructions. Following the protein transfer,
the PVDFmembranes were blocked for 1 hour at room temperature with 5% (w/v) non-fat dried milk in TBSwith 0.1% Tween 20. The
membranes were incubated at 4C overnight with the primary antibodies diluted in blocking solution: anti phospho-(Ser-1303)
GluN2B (1: 2000, Millipore), anti-phospho (Tyr-1472) GluN2B (1:2000, Millipore), anti-phospho (Ser1480) GluN2B (1:2000, Abcam),
anti-GluN2B (C terminus, 1:4000, BD Transduction Laboratories), anti-GluN2B (N terminus 1:2000, Thermo Fisher Scientific), anti-
GluN2A (N terminus, 1:1000, Thermo Fisher Scientific), anti-CamKiia (1:8000, Thermo Fisher Scientific), anti-ERK1/2 (1:2000, Cell
Signaling), anti-phospho ERK1/2 (1:2000, Cell Signaling) and anti-beta actin (1:200000, Abcam). For visualization of western blots,
HRP-based secondary antibodies were used followed by chemiluminescent detection on Kodak X-Omat film. Western blots were
digitally scanned and densitometric analysis was performed using ImageJ. All analysis involved normalizing to either GluN2B (for
phospho-GluN2B antibodies) or beta actin expression as a loading control.
Transfection of cortical neurons
Neuronswere transfected at DIV 7 using Lipofectamine 2000 (Invitrogen) according to themanufacturer’s suggested protocol as pre-
viously described (Bell et al., 2015). b-globin or pCis-GluN2A (Rutter and Stephenson, 2000) were co-transfected with enhanced
green fluorescent protein (eGFP), to identify transfected cells, in a ratio of 2:1. Transfection efficiency was approximately 5% with
> 99% of eGFP-expressing cells being identified as positive for the neuronal nuclear antigen (NeuN), while < 1% were positive for
glial fibrillary acidic protein (GFAP) (Hasel et al., 2017). Electrophysiological recordings were made from transfected neurons
72-96 h post transfection.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analysis, equipment and settings
Statistical testing involved a 2-tailed paired Student’s t test., or a one- or two-way ANOVA followed by Sidak’s post hoc test. Cell
death analyses for both in vitro and in vivo experiments were performed blind to the genotype/experimental condition. For western
blots, we used chemiluminescent detection on Kodak X-Omat film, and linear adjustment of brightness/contrast applied (Photoshop)
equally across the image, maintaining some background intensity. In some cases, lanes from non-adjacent lanes are spliced
together, but the lanes are always from the same blot, processed in the same way, and the splicing point is clearly marked. For
the analysis of electrophysiological data in MEA-based recordings (Figures 2J, 2K, and S2A), because several slices were routinely
recorded from every mouse, the values of the area under the I/O relationship (AUCI/O), values of peak fEPSP amplitudes evoked by
maximum stimulus strength and LTP in WT and mutant mice were compared by the two-way nested ANOVA with genotype (group)
andmice (sub-group) as fixed and random factors, correspondingly, with the Satterthwaite’s correction applied to calculate effective
degrees of freedom (STATISTICA v. 10, StatSoft, Inc., Tulsa, OK, USA). Statistical effects were considered significant if p < 0.05.
Statistical details of each experiment can be found within figure legends.Cell Reports 25, 841–851.e1–e4, October 23, 2018 e4
